{
    "2020-10-26": [
        [
            {
                "time": "",
                "original_text": "药明系又一家企业成功登陆港股 为何CXO企业纷纷偏爱做LP？",
                "features": {
                    "keywords": [
                        "药明系",
                        "CXO企业",
                        "港股",
                        "LP"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：医药板块短期调整 寻找长期优质标的",
                "features": {
                    "keywords": [
                        "医药生物",
                        "短期调整",
                        "长期优质标的"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "预期差引发白马股闪崩，三季报收官提前防雷",
                "features": {
                    "keywords": [
                        "预期差",
                        "白马股",
                        "闪崩",
                        "三季报"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "机构重仓股跟踪周报",
                "features": {
                    "keywords": [
                        "机构重仓股",
                        "跟踪周报"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "广药集团：旗下白云山制药总厂与药明康德签署1类创新药项目合作协议",
                "features": {
                    "keywords": [
                        "广药集团",
                        "白云山制药",
                        "药明康德",
                        "创新药",
                        "合作协议"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}